Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: A nationwide cohort study

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 11, 2015, Pages 1200-1209

  Fu, S C ^a   Huang, Y W ^a,b,c   Wang, T C ^a   Hu, J T ^a,d   Chen, D S ^c,e   Yang, S S ^a,d  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHRONIC HEPATITIS B; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; VERY ELDERLY; CARCINOMA, HEPATOCELLULAR; COMPLICATION; HEPATITIS B; HEPATITIS B VIRUS; INCIDENCE; ISOLATION AND PURIFICATION; LIVER NEOPLASMS; RISK; VIROLOGY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK; YOUNG ADULT;

EID: 84929132837     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13191     Document Type: Article

References (31)

1. Yang HI, Lu SN, Liaw YF, et al,. Hepatits B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347: 168-74.
2. Chen CJ, Yang HI, Su J, et al,. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73.
3. World Health Organization. Hepatitis B, 2009. Available at: http://www.who.int/mediacentre/factsheets/fs204/en/ (accessed September 19, 2009).
4. Shi Y, Hu FB,. The global implications of diabetes and cancer. Lancet 2009; 383: 1947-8.
5. World Health Organization. The top 10 causes of death, 2014. Available at: http://www.who.int/mediacentre/factsheets/fs310/en/ (accessed May 2014).
6. El-Serag HB, Tran T, Everhart JE,. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-8.
7. Polesel J, Zucchetto A, Montella M, et al,. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol 2009; 20: 353-7.
8. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB,. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005; 54: 533-9.
9. Lagiou P, Kuper H, Stuver SO, Tzonou A, Trichopoulos D, Adami HO,. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst 2000; 92: 1096-9.
10. El-Serag HB, Hampel H, Javadi F,. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006; 4: 369-80.
11. Wang C, Wang X, Gong G, et al,. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer 2012; 130: 1639-48.
12. Hassan MM, Hwang LY, Hatten CJ, et al,. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002; 36: 1206-13.
13. Li Q, Li WW, Yang X, et al,. Type 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B. Int J Cancer 2012; 131: 1197-202.
14. Yang X, Wang Y, Luk AO, et al,. Enhancers and attenuators of risk associations of chronic hepatitis B virus infection with hepatocellular carcinoma in type 2 diabetes. Endocr Relat Cancer 2013; 20: 161-71.
15. Chen CL, Yang HI, Yang WS, et al,. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008; 135: 111-21.
16. WHO Collaborating Centre for Drug Statistics Methodology. Oslo, Norway: Norwegian Institute of Public Health, ATC/DDD Index, 2013. Available at: http://www.whocc.no/atc-ddd-index/ (accessed December 19, 2013).
17. Deyo RA, Cherkin DC, Ciol MA,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-9.
18. Wu CY, Chen YJ, Ho HJ, et al,. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 2012; 308: 1906-14.
19. Gray RJ,. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-54.
20. Huang YW, Wang TC, Lin SC, et al,. Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study. Clin Infect Dis 2013; 57: 1695-702.
21. Loomba R, Abraham M, Unalp A, et al,. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 2012; 56: 943-51.
22. Zarrinpar A, Loomba R,. Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2012; 36: 909-21.
23. Farrell G,. Insulin resistance, obesity, and liver cancer. Clin Gastroenterol Hepatol 2014; 12: 117-9.
24. Vanni E, Bugianesi E,. Obesity and liver cancer. Clin Liver Dis 2014; 18: 191-203.
25. Sampson MJ, Hughes DA,. Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes. Diabetologia 2006; 49: 1726-31.
26. Yu ST, Chang HY, Lin MC, Lin YH,. Agreement between self-reported and health insurance claims on utilization of health care: a population study. J Clin Epidemiol 2009; 62: 1316-22.
27. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML,. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011; 20: 236-42.
28. Saunders D, Seidel D, Allison M, Lyratzopoulos G,. Systematic review: the association between obesity and hepatocellular carcinoma-epidemiological evidence. Aliment Pharmacol Ther 2010; 31: 1051-63.
29. Loomba R, Yang HI, Su J, et al,. Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men. Clin Gastroenterol Hepotol 2010; 8: 891-8.
30. Loomba R, Yang HI, Su J, et al,. Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prespective cohort study. Am J Epidemiol 2013; 177: 333-42.
31. Cabrera R, Nelson DR,. Review article: the management of hepatocellular carcinoma. Aliment Pharmacol Ther 2010; 31: 461-76.